Association between Neutrophil-to-Lymphocyte Ratio and Gut Microbiota in a Large Population: a Retrospective Cross-Sectional Study

[1]  Zongan Liang,et al.  The Association Between the Neutrophil-to-Lymphocyte Ratio and Mortality in Patients With Acute Respiratory Distress Syndrome: A Retrospective Cohort Study , 2019, Shock.

[2]  E. Yuliwati,et al.  A Review , 2019, Current Trends and Future Developments on (Bio-) Membranes.

[3]  Su Hwan Lee,et al.  High blood neutrophil-lymphocyte ratio associated with poor outcomes in miliary tuberculosis. , 2018, Journal of thoracic disease.

[4]  D. Velissaris,et al.  Correlation between neutrophil-to-lymphocyte ratio and severity scores in septic patients upon hospital admission. A series of 50 patients , 2018, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[5]  S. Oudard,et al.  Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients , 2018, PloS one.

[6]  D. Burke,et al.  Association of pretreatment neutrophil‐lymphocyte ratio and outcome in emergency colorectal cancer care , 2018, Annals of the Royal College of Surgeons of England.

[7]  Yeojun Yun,et al.  Correlation between gut microbiota and personality in adults: A cross-sectional study , 2017, Brain, Behavior, and Immunity.

[8]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[9]  A. Gasbarrini,et al.  Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders , 2017, Digestive Diseases.

[10]  Takao Takahashi,et al.  Increased neutrophil-to-lymphocyte ratio is a novel marker for nutrition, inflammation and chemotherapy outcome in patients with locally advanced and metastatic esophageal squamous cell carcinoma. , 2017, Biomedical reports.

[11]  I. Thiele,et al.  Gut microbiota functions: metabolism of nutrients and other food components , 2017, European Journal of Nutrition.

[12]  W. Liao,et al.  Influence of diet on the gut microbiome and implications for human health , 2017, Journal of Translational Medicine.

[13]  Philipp Koehn,et al.  Cognitive Psychology , 1992, Ageing and Society.

[14]  P. Forget,et al.  What is the normal value of the neutrophil-to-lymphocyte ratio? , 2017, BMC Research Notes.

[15]  P. Forget,et al.  The neutrophil-to-lymphocyte ratio: a narrative review , 2016, Ecancermedicalscience.

[16]  Julia Tzu-Ya Weng,et al.  Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males , 2016, PloS one.

[17]  G. Van Domselaar,et al.  The Gut Microbiota in Immune-Mediated Inflammatory Diseases , 2016, Front. Microbiol..

[18]  B. Baune,et al.  Elevated neutrophil to lymphocyte ratio predicts mortality in medical inpatients with multiple chronic conditions , 2016, Medicine.

[19]  B. Rahim-Williams,et al.  The microbiome of the oral mucosa in irritable bowel syndrome , 2016, Gut microbes.

[20]  R. Ley.  Gut microbiota in 2015: Prevotella in the gut: choose carefully , 2016, Nature Reviews Gastroenterology &Hepatology.

[21]  S. Dowd,et al.  Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice , 2016, PloS one.

[22]  A. K. Demir,et al.  The relationship between the neutrophil–lymphocyte ratio and disease activity in patients with ulcerative colitis , 2015, The Kaohsiung journal of medical sciences.

[23]  Y. Shan,et al.  Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity. , 2015, International journal of clinical and experimental pathology.

[24]  X. Gu,et al.  Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis , 2015, Scientific Reports.

[25]  Chris McSweeney,et al.  Association between specific mucosa‐associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study , 2015, Journal of gastroenterology and hepatology.

[26]  M. Ulu,et al.  Neutrophil-to-lymphocyte ratio in inflammatory bowel disease - as a new predictor of disease severity. , 2015, Bratislavske lekarske listy.

[27]  A. C. Tanrıkulu,et al.  The Relationship Between Inflammatory Marker Levels and Pulmonary Tuberculosis Severity , 2014, Inflammation.

[28]  I. Tanboğa,et al.  Correlation of Neutrophil to Lymphocyte Ratio With the Presence and Severity of Metabolic Syndrome , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[29]  Jacques Ravel,et al.  An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform , 2014, Microbiome.

[30]  M. Chiarini,et al.  Reduction of peripheral blood T cells producing IFN-γ and IL-17 after therapy with abatacept for rheumatoid arthritis. , 2014, Clinical and experimental rheumatology.

[31]  Ö. Ekiz,et al.  Neutrophil to lymphocyte ratio in Behçet's disease as a marker of disease activity. , 2014, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

[32]  Sarah L. Westcott,et al.  Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform , 2013, Applied and Environmental Microbiology.

[33]  F. Donskov.  Immunomonitoring and prognostic relevance of neutrophils in clinical trials. , 2013, Seminars in cancer biology.

[34]  A. Gewirtz,et al.  Faculty Opinions recommendation of Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. , 2013 .

[35]  T. Costantino,et al.  Neutrophil to lymphocyte ratio and cardiovascular diseases: a€review , 2012 .

[36]  Rob Knight,et al.  Advancing our understanding of the human microbiome using QIIME. , 2013, Methods in enzymology.

[37]  P. Marik,et al.  Narrative Review , 2012, Journal of intensive care medicine.

[38]  Y. Beyazit,et al.  Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity. , 2012, Clinics and research in hepatology and gastroenterology.

[39]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[40]  Yunwei Wang,et al.  Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10−/− mice , 2012, Nature.

[41]  L. Vannucci,et al.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases , 2011, Cellular and Molecular Immunology.

[42]  R. Knight,et al.  UniFrac: an effective distance metric for microbial community comparison , 2011, The ISME Journal.

[43]  E. K. Kemsley,et al.  Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota , 2010, BMC gastroenterology.

[44]  H. Nagawa,et al.  Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer , 2010, Radiation oncology.

[45]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[46]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[47]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[48]  Rustam I. Aminov,et al.  Predominant Role of Host Genetics in Controlling the Composition of Gut Microbiota , 2008, PloS one.

[49]  F. Schmidt.  Meta-Analysis , 2008 .

[50]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[51]  S. Miehlke,et al.  Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. , 2006, Journal of medical microbiology.

[52]  M. ChB.,et al.  Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer , 2005, Journal of surgical oncology.

[53]  S. Finegold,et al.  Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. , 2003, FEMS microbiology letters.

[54]  E. Zoetendal,et al.  The Host Genotype Affects the Bacterial Community in the Human Gastronintestinal Tract , 2001 .

[55]  R. Záhorec.  Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. , 2001, Bratislavske lekarske listy.

[56]  T. D. Du Clos,et al.  Function of C-reactive protein. , 2000 .

[57]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[58]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[59]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[60]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[61]  E. Baron.  Bilophila wadsworthia: a unique Gram-negative anaerobic rod. , 1997, Anaerobe.

[62]  D. Faith.  Conservation evaluation and phylogenetic diversity , 1992 .

[63]  W. Moore,et al.  Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress , 1976, Applied and environmental microbiology.

[64]  U. Neisser.  Cognitive Psychology: Classic Edition , 1967 .

[65]  E. C. Pielou.  The measurement of diversity in different types of biological collections , 1966 .